Literature DB >> 7261407

Serum pseudocholinesterase: high density lipoprotein cholesterol ratio as an index of risk for cardiovascular disease.

K M Kutty, R Jain, S Huang, K Kean.   

Abstract

A significant increase in the ratio of serum pseudocholinesterase/high density lipoprotein cholesterol (the Complementary Risk Factor ratio) was found in individuals classified as high risk for cardiovascular disease on the basis of the ratio of total cholesterol/high density lipoprotein cholesterol (the Established Risk Factor ratio) compared to the individuals with average and low risks. This Complementary Risk Factor ratio also showed good correlation with serum low density lipoprotein, triglycerides and the Established Risk Factor ratio. These results indicate that serum cholinesterase has a parallel relationship with low density lipoproteins and a reciprocal relationship with high density lipoproteins. We propose that the Complementary Risk Factor ratio may be an additional marker in predicting the risks for cardiovascular disease.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7261407     DOI: 10.1016/0009-8981(81)90106-6

Source DB:  PubMed          Journal:  Clin Chim Acta        ISSN: 0009-8981            Impact factor:   3.786


  4 in total

1.  Cholinesterase and paraoxonase (PON1) enzyme activities in Mexican-American mothers and children from an agricultural community.

Authors:  Veronica Gonzalez; Karen Huen; Subha Venkat; Kelly Pratt; Pin Xiang; Kim G Harley; Katherine Kogut; Celina M Trujillo; Asa Bradman; Brenda Eskenazi; Nina T Holland
Journal:  J Expo Sci Environ Epidemiol       Date:  2012-07-04       Impact factor: 5.563

2.  Relationship between serum pseudocholinesterase and triglycerides in experimentally induced diabetes mellitus in rats.

Authors:  V Annapurna; I Senciall; A J Davis; K M Kutty
Journal:  Diabetologia       Date:  1991-05       Impact factor: 10.122

3.  Altered brain cholinergic enzymes activity in the genetically obese rat.

Authors:  C B Goodman; K F Soliman
Journal:  Experientia       Date:  1991-08-15

4.  Butyrylcholinesterase as a prognostic marker: a review of the literature.

Authors:  Lidia Santarpia; Ilenia Grandone; Franco Contaldo; Fabrizio Pasanisi
Journal:  J Cachexia Sarcopenia Muscle       Date:  2012-09-06       Impact factor: 12.910

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.